Vierbaum, Laura
Wojtalewicz, Nathalie
Grunert, Hans-Peter
Zimmermann, Anika
Scholz, Annemarie
Goseberg, Sabine
Kaiser, Patricia
Duehring, Ulf
Drosten, Christian
Corman, Victor
Niemeyer, Daniela
Rabenau, Holger F.
Obermeier, Martin
Nitsche, Andreas
Michel, Janine
Puyskens, Andreas
Huggett, Jim F.
O’Sullivan, Denise M.
Busby, Eloise
Cowen, Simon
Vallone, Peter M.
Cleveland, Megan H.
Falak, Samreen
Kummrow, Andreas
Schellenberg, Ingo
Zeichhardt, Heinz
Kammel, Martin
Article History
Received: 8 November 2022
Accepted: 8 August 2023
First Online: 14 August 2023
Competing interests
: HZ declares that he was majority owner of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH, Berlin, and owner and managing director of IQVD GmbH - Institut fuer Qualitaetssicherung, Berlin. HPG declares that he was minority owner of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH, Berlin. HZ and HPG declare that they were managing directors of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH, Berlin, during the study. This does not alter our adherence to Nature Scientific Reports policies on sharing data and materials. All other authors have declared that no competing interests exist. The work from SF and AK was partially funded by EURAMET in the project 18HLT03 SEPTIMET. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. All other authors have no conflict of interest.